Anal Cancer
Research from M.M. Haapamaki et al Has Provided New Information about Anal Cancer
Published in Cancer Weekly, March 15th, 2011
2011 MAR 15 -- According to a study from Umea, Sweden, "This study aimed to evaluate the physical performance and quality of life after an extended abdominoperineal excision of the rectum and the reconstruction with a right-sided unilateral gluteus myocutaneus rotation flap in patients with rectal and anal cancer. Nineteen patients with primary or recurrent rectal or anal cancer were investigated a mean of 26 months (range, 10-39 mo) after the operation."
"All patients received preoperative radiation therapy. Physical performance, hip movability, balance, and ability to sit were measured according to a prospective protocol, and the patients' perception of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2011-03-15)
More Articles from Cancer Weekly
- Colon Cancer
Campaign Encourages Screening During Colon Cancer Awareness Month - Cancer Thrivers
Cancer Thrivers Respond to Recent Dateline Program - Colon Cancer
ColonCancerCheck and OHL Clubs Team Up to Fight Colorectal Cancer - Prostate Cancer
Data from Yale University Advance Knowledge in Prostate Cancer - Cancer Research
Data on Cancer Research Published by Researchers at St. Michael's Hospital - Lung Cancer
Data on Lung Cancer Reported by Researchers at Baylor College of Medicine, Department of Neurosurgery - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
